| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | LQDA Liquidia Corporation | Bloch Stephen M | Director | Sell | 78,596 | $79.97 | $6,285,250.24 | -3.5% | - | - | |
| Jul 20, 2026 | JNJ Johnson & Johnson | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 23,054 | $251.27 | $5,792,686.36 | -50.1% | - | - | |
| Jul 16, 2026 | AQST Aquestive Therapeutics, Inc. | Barber Daniel77 | President And CEO | Sell | 25,000 | $4.01 | $100,191.90 | -2.0% | - | - | |
| Jul 16, 2026 | INM Inmed Pharmaceuticals Inc. | Vivo Opportunity, LLC67 | 10% Owner | Buy | 20,546 | $1.55 | $31,846.30 | +0.8% | - | - | |
| Jul 15, 2026 | INM Inmed Pharmaceuticals Inc. | Adar1 Capital Management, LLC73 | 10% Owner | Buy | 1,000 | $1.56 | $1,555.00 | +0.1% | - | - | |
| Jul 14, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $526.83 | $5,004,908.72 | -2.4% | - | - | |
| Jul 14, 2026 | ETON Eton Pharmaceuticals, Inc. | Opaleye Management Inc.60 | 10% Owner | Sell | 28,315 | $37.54 | $1,063,032.88 | -1.0% | - | - | |
| Jul 14, 2026 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Hrt Financial LP | 10% Owner | Sell | 83,149 | $4.48 | $372,703.79 | -58.0% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Khindri Sanjeev | Chief Development Officer | Sell | 1,185 | $71.51 | $84,740.28 | -0.9% | - | - | |
| Jul 13, 2026 | ANIP Ani Pharmaceuticals, Inc. | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 500 | $81.84 | $40,920.00 | -0.6% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Adair Jason | Chief Business Officer | Sell | 7,863 | $71.51 | $562,288.70 | -1.7% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Schundler Russell57 | General Counsel | Sell | 14,738 | $71.51 | $1,053,925.78 | -1.2% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Krepp Sarah | Chief Human Resource Officer | Sell | 7,864 | $71.51 | $562,360.74 | -3.2% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Jeffs Roger64 | Chief Executive Officer | Sell | 35,249 | $71.51 | $2,520,682.83 | -1.5% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Kaseta Michael55 | CFO And COO | Sell | 20,430 | $71.51 | $1,460,964.71 | -2.8% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Moomaw Scott | Chief Commercial Officer | Sell | 9,539 | $71.51 | $682,141.53 | -2.5% | - | - | |
| Jul 13, 2026 | LQDA Liquidia Corporation | Saggar Rajeev | Chief Medical Officer | Sell | 9,926 | $71.51 | $709,816.13 | -2.7% | - | - | |
| Jul 10, 2026 | AMLX Amylyx Pharmaceuticals, Inc. | Mazzariello Gina53 | Chief Legal Officer | Sell | 30,000 | $17.96 | $538,867.50 | -7.4% | - | - | |
| Jul 10, 2026 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Hrt Financial LP | 10% Owner | Buy | 8,997 | $3.36 | $30,212.49 | +8.0% | - | - | |
| Jul 9, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $551.13 | $5,235,756.07 | -2.6% | - | - | |
| Jul 9, 2026 | NBIX Neurocrine Biosciences, Inc. | Delaet Ingrid66 | Chief Regulatory Officer | Sell | 14,571 | $178.65 | $2,603,111.99 | -23.0% | - | - | |
| Jul 8, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $553.17 | $5,255,111.50 | -1.8% | - | - | |
| Jul 8, 2026 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Hrt Financial LP | 10% Owner | Sell | 29,111 | $3.45 | $100,460.52 | -19.1% | - | - | |
| Jul 7, 2026 | IRWD Ironwood Pharmaceuticals, Inc. | Silver Ronald68 | Pfo &Pao | Sell | 127,890 | $4.52 | $578,062.80 | -29.0% | - | - | |
| Jul 6, 2026 | UTHR United Therapeutics Corporation | Rothblatt Martine A58 | Chairperson &CEO | Sell | 9,500 | $548.96 | $5,215,133.38 | -2.7% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.